Adlai Nortye Ltd. (ANL)
NASDAQ: ANL · IEX Real-Time Price · USD
3.790
+0.080 (2.16%)
At close: Jul 2, 2024, 3:59 PM
3.580
-0.210 (-5.54%)
After-hours: Jul 2, 2024, 6:05 PM EDT
Adlai Nortye Revenue
In the year 2023, Adlai Nortye had annual revenue of $5.00M.
Revenue (ttm)
$5.00M
Revenue Growth
n/a
P/S Ratio
12.06
Revenue / Employee
$39,370
Employees
127
Market Cap
61.76M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 5.00M | - | - |
Dec 31, 2022 | 0 | - | - |
Dec 31, 2021 | 45.73M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionANL News
- 5 weeks ago - Adlai Nortye Ltd. to Present Encouraging Data of the Combination of AN0025 and Definitive Chemoradiotherapy (dCRT) at ASCO 2024 - GlobeNewsWire
- 5 weeks ago - Adlai Nortye Announces First Patient Dosed in Randomized Phase II Clinical Trial of Palupiprant (AN0025) for the Treatment of Locally Advanced Rectal Cancer with Radiation Therapy - GlobeNewsWire
- 3 months ago - Adlai Nortye Announces Appointment of Dr. Archie Tse as the Head of Research & Development - GlobeNewsWire
- 8 months ago - Adlai Nortye Announces Completion of Patient Enrollment in Global Phase III Clinical Trial of Buparlisib (AN2025) in Combination with Paclitaxel for the Treatment of Recurrent or Metastatic HNSCC - GlobeNewsWire
- 9 months ago - Adlai Nortye Ltd. & Nucleai awarded ESMO 2023 BEST Poster Award - GlobeNewsWire
- 9 months ago - Adlai Nortye Ltd. Announces Closing of Initial Public Offering - GlobeNewsWire
- 9 months ago - Adlai Nortye Ltd. Announces Pricing of Initial Public Offering - GlobeNewsWire
- 11 months ago - Cancer treatment company Adlai Nortye sets terms in IPO - Market Watch